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A little more than 50 years ago Pfeiffer [1] noted that the
more active a chiral drug was, the less active its enanti-
omer was. Recent years have seen increased success in
screening compounds in silico. While the majority of 2D
screening approaches are insensitive to stereochemistry,
this is not the case in 3D docking, which is typically used
to refine compound lists. Unfortunately, a number of
common workflows result in generation of only one
member of the number of structures actually registered in
a 2D database [2]. This results in a fraction of candidate
structures being ignored in silico, even though they are
present in the real compound libraries being considered.
How big is the omitted chemistry space? What fraction of
compounds in common databases are racemic mixtures,
and how common are diastereomers and meso-com-
pounds?
We will present workflows using KNIME to explore some
of these questions, to properly enumerate specific stereoi-
somers present in molecular collections and to qualify the
effects of enumeration on 3D compound screening.
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